We are live on ! Find out more
CLPT icon

ClearPoint Neuro

76 hedge funds and large institutions have $102M invested in ClearPoint Neuro in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 9

122% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 9

69% more call options, than puts

Call options by funds: $4M | Put options by funds: $2.37M

56% more capital invested

Capital invested by funds: $65.6M → $102M (+$36.5M)

52% more funds holding

Funds holding: 5076 (+26)

10.81% more ownership

Funds ownership: 15.01%25.82% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
76
Holders Change
+26
Holders Change %
+52%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
20
Reduced
9
Closed
9
Calls
$4M
Puts
$2.37M
Net Calls
+$1.63M
Net Calls Change
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$21.9M +$16M +829,123 +259%
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.7M +$3.22M +166,851 +25%
PGM
3
Parian Global Management
New York
$13M +$2.05M +105,906 +18%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$5.25M +$3.08M +159,353 +137%
State Street
5
State Street
Massachusetts
$5.23M +$5.3M +274,049 New
Northern Trust
6
Northern Trust
Illinois
$3.37M +$2.88M +148,904 +541%
TFCM
7
Taylor Frigon Capital Management
Arizona
$3.35M +$2.31M +119,773 +214%
KC
8
Kepos Capital
New York
$2.39M
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$2.24M +$530K +27,427 +31%
CCM
10
Conway Capital Management
California
$2.22M +$600K +31,075 +36%
PCM
11
Parsons Capital Management
Rhode Island
$1.98M +$58K +3,000 +3%
RA
12
Royce & Associates
New York
$1.74M +$692K +35,800 +65%
Marshall Wace
13
Marshall Wace
United Kingdom
$1.08M +$1.09M +56,391 New
JP Morgan Chase
14
JP Morgan Chase
New York
$1.01M +$175K +9,050 +21%
Millennium Management
15
Millennium Management
New York
$974K -$2.72M -140,764 -73%
AA
16
AlphaCentric Advisors
Puerto Rico
$955K
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$921K +$932K +48,255 New
Renaissance Technologies
18
Renaissance Technologies
New York
$911K -$539K -27,900 -37%
Charles Schwab
19
Charles Schwab
California
$883K +$893K +46,216 New
Goldman Sachs
20
Goldman Sachs
New York
$879K +$406K +21,018 +84%
KMC
21
Kirr Marbach & Co
Indiana
$863K +$100K +5,200 +13%
N
22
Nuveen
North Carolina
$850K +$861K +44,545 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$829K +$839K +43,440 New
Citadel Advisors
24
Citadel Advisors
Florida
$773K +$783K +40,500 New
ACA
25
Apis Capital Advisors
New York
$764K +$773K +40,000 New

CLPT Hedge Fund Activity: Q2 2021 in Review

76 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2021, worth a combined $102M — up 56% from $65.6M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CLPT positions and 9 closed out — a net gain of 26 holders — while 20 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $16M. The largest seller was Millennium Management, cutting an estimated $2.72M.

  • 76 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2021, up from 50 in Q1 2021.
  • Funds reported $102M of ClearPoint Neuro stock for Q2 2021, up 56% quarter-over-quarter.
  • 35 funds opened new ClearPoint Neuro positions in Q2 2021 and 9 closed out, a net change of +26 holders.
  • The largest ClearPoint Neuro buyer in Q2 2021 was BlackRock, an estimated $16M added.
  • The largest ClearPoint Neuro seller in Q2 2021 was Millennium Management, an estimated $2.72M sold.

Based on aggregated 13F filings for Q2 2021.